ICBs attenuated IL-17 production by T cells in the presence of ACM, which may be beneficial in dampening tumour-promoting inflammatory responses in the OGJ setting, given its incidence is strongly associated with obesity-driven inflammation (O’Sullivan 2018). Here, IL17A is linked to obesity due to melanocortin 4 receptor deficiency.